A Better Way To DNA

Novel Bio designs and scales plasmid DNA to overcome the DNA bottleneck in drug discovery.

Plasmid DNA manufacturing is stuck in the 70s

For decades, the world’s labs have relied on E. coli to make pDNA. But its limitations have created a DNA bottleneck, leaving countless medicines on the R&D shelf.

Meet the NBx Platform™

NBx makes plasmid DNA with higher yield, speed, and quality than today’s systems and is fully compatible with existing workflows. NBx scales quality pDNA to help reduce development timelines, minimize costly failures, and enable first-of-their-kind medicines.

  • Higher yield

  • Faster growth

  • Better quality

Now you can have the power of NBx in your very own lab. Introducing:

NBx CyClone™

Chemically Competent Cells

Take the stress out of DNA cloning and alleviate your biggest pain points

  • Speed - 3X faster workflows than E. coli 

  • Complexity -  Maintain sequence motifs E. coli can’t handle 

  • Superior yield & quality – Get more out of your R&D

Early Access Program Launching May 2025

We scale your DNA to clinic

We combine personalized expert service with our NBx Platform to scale your most difficult DNA designs. Whether it’s cell and gene therapy, RNA therapeutics, or nucleic acid vaccines, we accelerate genetic medicines to the clinic.

We are DNA
Experts. Problem Solvers. Artists. Entrepreneurs.

We set out to overcome the DNA bottleneck that keeps genetic medicines from patients. With our unique expertise in DNA, we believe we solve this fundamental problem and contribute to biotech in a big way.